OCT 07, 2015 1:22 PM PDT

New Protein Found in B Lymphocytes

WRITTEN BY: Kara Marker
Scientists from the University of Freiburg published in the Journal of Experimental Medicine their findings of protein Kidins220/ARMS present in B lymphocytes. The protein was discovered in the past couple of years to be present in T lymphocytes and nerve cells, but the Freiburg study was the first to show its existence in B lymphocytes. 

Cell signaling between a B cell receptor (BCR) and antigens present on the surface of pathogens invading the body is a key process for the production of antibodies. This new study showed how Kidins220/ARMS protein interacts with the BCR by regulating signaling pathways between the receptor and the interior of the cell. Without Kidins220/ARMS, B lymphocytes would not be able to make as many antibodies to fight off infection, weakening the entire force of humoral immunity. 

Kidins220/ARMS was also found to directly impact B cell production. In experimental mice that did not produce the protein, "the deficiency obstructed the development of B cells." 

"This knowledge could help to develop new medications for autoimmune diseases or other illnesses in the future," notes Dr. Wolfgang Schamel, an immunobiologist involved in the study. 
A drawing of Kidins220/ARMS interacting with the BCR
In 2011, the European Journal of Immunology published results of Kidins220/ARMS protein discovered in T lymphocytes. In this environment, Kidins220/ARMS is a "novel component of the regulation of T cell moitlity, and essential process for the immune response." Unlike B cells and humoral immunity, T cells are involved with cell-mediated immunity. This includes the release of cytokines and activation of B cells, cytotoxic T cells, and phagocytes.

Similarly in Cell Death and Differentiation, Kidins220/ARMS was shown to regulate neurotrophin and vascular endothelial factor. These are proteins important to the survival, development, and function of neurons and blood cells, respectively.

Watch the Khan Academy video below to learn more about the understanding of B cell production and development. 

Source: Science Daily 

 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
OCT 12, 2021
Health & Medicine
Atopic Dermatitis: A Harbinger of Autoimmune Diseases?
OCT 12, 2021
Atopic Dermatitis: A Harbinger of Autoimmune Diseases?
New research published in Allergy, Asthma & Clinical Immunology found an increased risk of autoimmune disease develo ...
NOV 10, 2021
Health & Medicine
Zinc for Respiratory Infections
NOV 10, 2021
Zinc for Respiratory Infections
With zinc sales climbing during the pandemic and in vitro studies showing the mineral fights respiratory viruses, includ ...
NOV 25, 2021
Immunology
What's a T Cell COVID Vaccine and Could It Be Better Than What We Have?
NOV 25, 2021
What's a T Cell COVID Vaccine and Could It Be Better Than What We Have?
All vaccines train the immune system to recognize and wage war against pathogens such as viruses and bacteria. However, ...
DEC 07, 2021
Immunology
Ancient Medicine and Synthetic Biology Collide to Combat Chemo Resistance
DEC 07, 2021
Ancient Medicine and Synthetic Biology Collide to Combat Chemo Resistance
  Strong chemical drugs used to obliterate all rapidly growing cells in the body have been used to treat cancer sin ...
DEC 27, 2021
Cancer
Improving Immunotherapy with a Novel Nanoparticle
DEC 27, 2021
Improving Immunotherapy with a Novel Nanoparticle
Malignant pleural effusion (MPE) occurs in cancer patients experiencing a buildup of fluid and tumor cells in the pleura ...
JAN 13, 2022
Cancer
An Arthritis Drug Combats Chemoresistance in Pancreatic Cancer
JAN 13, 2022
An Arthritis Drug Combats Chemoresistance in Pancreatic Cancer
The American Cancer Society estimates the lifetime risk of pancreatic cancer at about 1 in 64. Pancreatic duct ...
Loading Comments...